| Dr Nigel James Arruda, MD | |
|
2637 Midpoint Dr Ste B, Fort Collins, CO 80525-4408 | |
| (970) 488-1666 | |
| Not Available |
| Full Name | Dr Nigel James Arruda |
|---|---|
| Gender | Male |
| Speciality | Hospitalist |
| Experience | 7 Years |
| Location | 2637 Midpoint Dr Ste B, Fort Collins, Colorado |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1972036556 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | 01090222A (Indiana) | Primary |
| 207R00000X | Internal Medicine | DR.0063691 (Colorado) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Uchealth Greeley Hospital | Greeley, CO | Hospital |
| Poudre Valley Hospital | Fort collins, CO | Hospital |
| Eskenazi Health | Indianapolis, IN | Hospital |
| Medical Center Of The Rockies | Loveland, CO | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eskenazi Medical Group Inc | 4284546813 | 125 |
News Archive
The search by scientists to find ways to combat obesity continues. Recently, investigators have been exploring whether they can engage the lymphatic system to help regulate obesity-induced inflammation of fat (adipose) tissue and restore systemic metabolic fitness.
Biomagnetics Diagnostics Corp., a developer of revolutionary technology for diagnostic systems for HIV, hepatitis, tuberculosis and malaria detection, today announced the signing of an agreement with Los Alamos National Security, LLC where Los Alamos National Laboratory's scientific and engineering staffs will attempt to identify new potential human tuberculosis biomarkers and will develop a validated assay to detect human tuberculosis using a currently known biomarker to be used in combination with the waveguide-based optical biosensor platform.
Companies involved in the life science tools market must consider a multitude of technologies, economic drivers and societal trends in developing strategies for the future.
Horizon Therapeutics plc today announced results of a U.S. physician survey showing that endocrinologists and ophthalmologists perceive Thyroid Eye Disease to have a significant burden on their patients' quality of life.
Almost half of adults with type 2 diabetes report acute and chronic pain, and close to one quarter report neuropathy, fatigue, depression, sleep disturbance and physical or emotional disability, according to a study of more than 13,000 adults conducted by researchers at the San Francisco VA Medical Center, the University of California, San Francisco and the Kaiser Permanente Division of Research in Oakland, CA. The researchers also found significant rates of shortness of breath, nausea and constipation.
› Verified 6 days ago
| Entity Name | Eskenazi Medical Group Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730451063 PECOS PAC ID: 4284546813 Enrollment ID: O20031103000440 |
News Archive
The search by scientists to find ways to combat obesity continues. Recently, investigators have been exploring whether they can engage the lymphatic system to help regulate obesity-induced inflammation of fat (adipose) tissue and restore systemic metabolic fitness.
Biomagnetics Diagnostics Corp., a developer of revolutionary technology for diagnostic systems for HIV, hepatitis, tuberculosis and malaria detection, today announced the signing of an agreement with Los Alamos National Security, LLC where Los Alamos National Laboratory's scientific and engineering staffs will attempt to identify new potential human tuberculosis biomarkers and will develop a validated assay to detect human tuberculosis using a currently known biomarker to be used in combination with the waveguide-based optical biosensor platform.
Companies involved in the life science tools market must consider a multitude of technologies, economic drivers and societal trends in developing strategies for the future.
Horizon Therapeutics plc today announced results of a U.S. physician survey showing that endocrinologists and ophthalmologists perceive Thyroid Eye Disease to have a significant burden on their patients' quality of life.
Almost half of adults with type 2 diabetes report acute and chronic pain, and close to one quarter report neuropathy, fatigue, depression, sleep disturbance and physical or emotional disability, according to a study of more than 13,000 adults conducted by researchers at the San Francisco VA Medical Center, the University of California, San Francisco and the Kaiser Permanente Division of Research in Oakland, CA. The researchers also found significant rates of shortness of breath, nausea and constipation.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Nigel James Arruda, MD 2637 Midpoint Dr Ste B, Fort Collins, CO 80525-4408 Ph: (970) 488-1666 | Dr Nigel James Arruda, MD 2637 Midpoint Dr Ste B, Fort Collins, CO 80525-4408 Ph: (970) 488-1666 |
News Archive
The search by scientists to find ways to combat obesity continues. Recently, investigators have been exploring whether they can engage the lymphatic system to help regulate obesity-induced inflammation of fat (adipose) tissue and restore systemic metabolic fitness.
Biomagnetics Diagnostics Corp., a developer of revolutionary technology for diagnostic systems for HIV, hepatitis, tuberculosis and malaria detection, today announced the signing of an agreement with Los Alamos National Security, LLC where Los Alamos National Laboratory's scientific and engineering staffs will attempt to identify new potential human tuberculosis biomarkers and will develop a validated assay to detect human tuberculosis using a currently known biomarker to be used in combination with the waveguide-based optical biosensor platform.
Companies involved in the life science tools market must consider a multitude of technologies, economic drivers and societal trends in developing strategies for the future.
Horizon Therapeutics plc today announced results of a U.S. physician survey showing that endocrinologists and ophthalmologists perceive Thyroid Eye Disease to have a significant burden on their patients' quality of life.
Almost half of adults with type 2 diabetes report acute and chronic pain, and close to one quarter report neuropathy, fatigue, depression, sleep disturbance and physical or emotional disability, according to a study of more than 13,000 adults conducted by researchers at the San Francisco VA Medical Center, the University of California, San Francisco and the Kaiser Permanente Division of Research in Oakland, CA. The researchers also found significant rates of shortness of breath, nausea and constipation.
› Verified 6 days ago
Dr. Jennifer Levy Woelk, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr Ste B, Fort Collins, CO 80525 Phone: 970-488-1666 Fax: 970-472-9381 | |
Victoria Anne Clipsham, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr Ste B, Fort Collins, CO 80525 Phone: 970-488-1666 Fax: 970-472-9381 | |
Dr. Nancy Terrell Maller, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr Ste B, Fort Collins, CO 80525 Phone: 970-488-1666 Fax: 970-472-9381 | |
Mrs. Kelly Elizabeth Mistry, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr Ste B, Fort Collins, CO 80525 Phone: 434-243-4394 Fax: 434-243-4873 | |
Dr. Rebecca Rain Jackson, DO Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 1032 Luke St Ste 1, Fort Collins, CO 80524 Phone: 970-568-5810 | |
Eduardo Cruz Pareja, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr, Fort Collins, CO 80525 Phone: 970-488-1666 | |
Dr. Nathan Michael Smith, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2637 Midpoint Dr Ste B, Fort Collins, CO 80525 Phone: 970-488-1666 |